SC Adult Single inj of 30 mg. In case of insufficient relief or symptom recurrence, 2nd & 3rd inj can be administered at 6-hr intervals. Max: 3 inj in 24-hr period. Childn & adolescent 2-17 yr & weighing >65 kg 30 mg, 51-65 kg 25 mg, 41-50 kg 20 mg, 26-40 kg 15 mg, 12-25 kg 10 mg.
1st treatment should be given in a medical institution or under physician's guidance for patients who have never received Firazyr previously. Patients w/ laryngeal attacks; acute ischemic heart disease or unstable angina pectoris; history of or recent stroke. Minor influence on the ability to drive & use machines. Should be used during pregnancy only if the potential benefit justifies the potential risk for the foetus. Breastfeeding women should not breastfeed for 12 hr after treatment. Safety & efficacy in childn <2 yr or weighing <12 kg has not been established. Limited information on elderly >65 yr.
Sign Out
